David Y.T. Chen, MD, FACS

David Chen headshot
​​
This physician is not currently rated. Why?

Why is this doctor not rated?

Close

To ensure the accuracy of our patient satisfaction scores, we require that providers who see patients receive a minimum number of completed patient-submitted surveys before their reviews are listed on their profiles. Star ratings on this site are collected on a rolling basis from the previous 12 months.
Additionally, some of the physicians listed on our site do not see patients directly, and therefore, do not receive evaluation and ratings from patients.

More about patient ratings
Request an Appointment

Professor, Department of Urology

Associate Director, Urologic Oncology Fellowship Program 

Associate Chief Academic Officer

Treatment Focus

Urinary Diversions, Minimally Invasive Surgical Techniques - Laparoscopic, Robotic Surgery, Robotic Surgery and Urologic cancer ablation therapy (cryosurgery or HIFU)

Research Program

Key Awards

2023 top doctors
Urology

Treatment Philosophy

I am a urologic oncologist specializing in surgical treatment of cancers of the genitourinary tract. I have extensive experience with laparoscopic and minimally invasive surgical techniques and apply these approaches routinely to reduce the pain, recovery time, and complications associated with traditional open surgery.

I am skilled in nerve-sparing and organ-reconstructive surgery essential for preserving normal functions when treating prostate, testis, bladder and kidney cancer. I am sensitive to the particular issues regarding the diagnosis of genitourinary cancer and its subsequent treatment, including its physical and emotional effects on the patient and their family and support system.

I recognize each person is unique and requires a treatment individually tailored to them to achieve successful cancer treatment, limited treatment-related side effects and maintained quality of life.

Follow on Twitter: @dytcmd

Educational Background

  • Fellow/National Institutes of Health Research Scholar, Howard Hughes Medical Institute, Bethesda, MD
  • Fellow, Urologic Oncology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY
  • Resident, Urology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY
  • MD, Weill Cornell Medical Center, Cornell University, New York, NY, 1997

     

Certifications

  • American College of Surgeons
  • American Board of Urology

Memberships

  • Society of Laparoendoscopic Surgeons
  • American Urological Association
  • Philadelphia Urological Society
  • Eastern Cooperative Oncology Group (ECOG)
  • Society of Urologic Oncology

Honors & Awards

  • Philadelphia Magazine Top Doctors, 2011-20
  • Main Line Today Top Doctors, 2018-2019
  • Best Doctors in America® , 2019-2020, Urology
  • America’s Top Doctors®, 2011-18
Gary Cavallo

Gary Cavallo

  • Prostate Cancer

At 73, I’m totally invested in my health and vigilant about keeping up with my doctors’ visits. When I went to my primary care physician in 2020, he alerted me that my PSA level was up, an indication that I had a problem with my prostate. I know the normal range is from 1 to 4. Mine was 5.2. “We’ll take another PSA down the road,” the doctor said. We did another one, and that was 5.6.

VIEW PATIENT STORY
Peter Grove

Peter Grove

  • Bladder Cancer
  • Prostate Cancer
  • Ureteral Cancer

Nineteen years ago, just after I turned 60, I was diagnosed with bladder cancer. I had noticed some blood in my urine, and the first doctor I talked to told me not to worry about it. Then over the next few months it got worse, and I decided to go to Fox Chase Cancer Center.

VIEW PATIENT STORY
Donald Hawkins

Donald Hawkins

  • Bladder Cancer

I’m 80 years old, and my wife and I live in Ambler, Pennsylvania, a suburb of Philadelphia. I’m a retired information scientist, but I still work as a consultant and write a regular column about information science events.

I was diagnosed with bladder cancer about five years ago. I have lupus, but I see a rheumatologist regularly and have kept the condition under control with medicine for years. Therefore, when I started seeing blood in my urine, I knew something else was going on.

VIEW PATIENT STORY

Selected Publications

Correa AF, Handorf E, Joshi SS, Geynisman DM, Kutikov A, Chen DY, Uzzo RG, Viterbo R, Greenberg RE, Smaldone MC. Differences in Survival Associated with Performance of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database. J Urol, 199(5):1238-44, 2018. PubMed

Martin JM, Handorf EA, Price RA, Cherian G, Buyyounouski MK, et al. Medical dosimetry : official journal of the American Association of Medical Dosimetrists. 2015; 40(3):186-9. NIHMSID: NIHMS656177 PubMed

Hypoalbuminaemia is associated with mortality in patients undergoing cytoreductive nephrectomy. Corcoran AT, Kaffenberger SD, Clark PE, Walton J, Handorf E, et al. BJU international. 2015; 116(3):351-7. PubMed 

Additional Publications

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient comments

Loading ...
​​